Skip to main content
Uncategorized

La Marató de TV3 promotes the project run by the CIBER-BBN for the treatment of Fabry´s disease, in which the PCB is taking part.

By 21 de October de 2010November 18th, 2020No Comments
< Back to news
 21.10.2010

La Marató de TV3 promotes the project run by the CIBER-BBN for the treatment of Fabry´s disease, in which the PCB is taking part.

Twenty biomedical research projects on rare diseases will benefit from the more than 7M€ that were raised in the last edition of the de La Marató de TV3 telethon. Among these is the project led by the Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), in which, beside others, the Peptide and Nanoparticles Chemistry research team of the Barcelona Science Park and the Bionanophotonics Division of the Institute for Bioengineering of Catalonia (IBEC). The fund awarding event was held yesterday at the Auditorium at the Barcelona Biomedical Research Park.

Fabry´s disease is one of the more than 5,000 recognised rare diseases that affects a limited number of the population. It is a hereditary disease that affects the X chromosome and that prevents the body from producing a sufficient amount of alpha falactosidase A, which is necessary for the elimination a fatty substance (GL-3) in some cells of the body and prevents its accumulation so that these cells continue working correctly. At present it is estimated that one out of each 150,000 people suffers from this disease and the only treatment available is very costly.

The CIBER-BBN is composed of 50 research teams and one of the new CIBER consortiums that exists in our country. Its creation has been driven by the Institut de Salut Carlos III (ISCIII) to promote research of excellence and the critical mass of researches in the field of biomedicine and health sciences.

The Fundació La Marató has also awarded a research project to Xavier Salvatella, head of the Molecular Biophysics Group at the Institute for Research in Biomedicine (IRB Barcelona), located at the PCB. Salvatella will coordinate the three-year project entitled “Identification of the androgen receptor aggregates that cause spinal and bulbar muscular atrophy” (or Kennedy’s disease), funded with 396,632 €. The research groups headed by Eva Estébanez-Perpiñá at IBUB and by Leila Luheshi at the University of Cambridge will also participate in this project.

For more information